Renaissance Technologies Portfolio in 2026: Top Holdings & Recent Changes
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Jim Simons' legendary Renaissance Technologies portfolio showcases the quant powerhouse's signature high-velocity trading style in its latest Q4 2025 13F filing. The firm's $64.5B portfolio reveals dramatic moves across tech, biotech, and consumer giants, with explosive additions like NFLX up 2,544% and COST surging 5,220%, signaling algorithmic conviction in high-momentum names amid a shrinking position count.
Portfolio Snapshot: Quant Precision in a Sprawling $64B Universe
Portfolio Highlights (Q4’2025): - Market Value: $64.5B - Top 10 Holdings: 12.1% - Portfolio Size: 3184 -416 - Average Holding Period: 16 quarters - Turnover: 34.1%
Renaissance Technologies' Q4 2025 portfolio exemplifies the firm's quant-driven approach, maintaining a massive scale with 3,184 positions while trimming overall exposure by 416 holdings. The top 10 holdings represent just 12.1% of the portfolio, underscoring a deliberate lack of concentration typical of their systematic, data-intensive strategy that spans thousands of bets to harvest small edges across markets. This structure allows Renaissance to deploy sophisticated algorithms that thrive on high turnover—clocking in at 34.1%—while the 16-quarter average holding period hints at a blend of short-term tactical trades and longer-term statistical arbitrages.
The portfolio's evolution reflects adaptive quant models navigating 2025's volatile tech rally and sector rotations, with significant reductions in select names balanced by bold initiations and ramps. At $64.5B, this remains one of the largest 13F disclosures, offering retail investors a window into Renaissance's black-box brilliance without revealing the full high-frequency playbook. Tracking these shifts via ValueSense highlights how even ultra-diversified giants adjust to regime changes in volatility and momentum.
Top Positions Breakdown: Explosive Adds in Tech and Biotech Powerhouses
Renaissance's top holdings spotlight aggressive portfolio tweaks, led by Palantir Technologies Inc. (PLTR) at 2.4% after an Add 2.70%, holding 8.8M shares worth $1.56B. United Therapeutics Corporation (UTHR) follows at 1.4% $930M, trimmed by Reduce 12.15%, while Micron Technology, Inc. (MU) exploded with Add 151.03% to claim 1.3% ($859M via 3M shares), signaling bullishness on semiconductors.
The action intensifies with Kinross Gold Corporation (KGC) at 1.1% $703M, down Reduce 4.24% on 25M shares, and VeriSign, Inc. (VRSN) cut Reduce 12.33% to 1.0% $675M. Mega-moves dominate lower ranks: Netflix, Inc. (NFLX) rocketed Add 2,544.63% to 1.0% ($673M, 7.2M shares), Tesla, Inc. (TSLA) surged Add 220.88% to 1.0% $613M, and Exelixis, Inc. (EXEL) shed Reduce 10.00% to 0.9% $610M.
Rounding out the top 10, Costco Wholesale Corporation (COST) saw an astonishing Add 5,220.96% to 0.9% $598M, Carvana Co. (CVNA) boosted Add 38.92% to 0.9% $594M, blending AI/data plays like PLTR with biotech (UTHR, EXEL), chips (MU), streaming (NFLX), EVs (TSLA), retail (COST), and disruptors (CVNA). These shifts across 10 key names reveal Renaissance doubling down on momentum leaders while pruning laggards.
Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.
Want to see what we'll uncover next - before everyone else does?
Find Hidden Gems First!
What the Portfolio Reveals: Momentum Hunting in a Quant Playground
Renaissance's Q4 moves paint a picture of algorithmic agility, favoring high-momentum tech and growth names like PLTR, NFLX, TSLA, and MU amid AI and semiconductor booms. Biotech exposure via UTRH and EXEL persists despite trims, suggesting models still find alpha in healthcare volatility, while gold via KGC reflects tactical commodity hedges.
Sector skew toward technology (over 50% implied in tops) dominates, with consumer (COST, CVNA) and materials adding diversification in a sprawling 3,184-stock web. No overt dividend focus—turnover at 34% prioritizes short-to-medium trades over income. Risk management shines in ultra-low top-10 concentration 12.1%, spreading bets to mitigate blowups while scaling winners like COST's 5,000%+ ramp.
Geographically U.S.-centric, the portfolio leverages domestic growth engines, with position cuts -416 indicating disciplined pruning of underperformers per quant signals.
Portfolio Concentration Analysis
| Position | Value | % of Portfolio | Recent Change |
|---|---|---|---|
| Palantir Technologies Inc. (PLTR) | $1,563.6M | 2.4% | Add 2.70% |
| United Therapeutics Corporation (UTHR) | $930.3M | 1.4% | Reduce 12.15% |
| Micron Technology, Inc. (MU) | $859.4M | 1.3% | Add 151.03% |
| Kinross Gold Corporation (KGC) | $703.3M | 1.1% | Reduce 4.24% |
| VeriSign, Inc. (VRSN) | $675.2M | 1.0% | Reduce 12.33% |
| Netflix, Inc. (NFLX) | $673.0M | 1.0% | Add 2,544.63% |
| Tesla, Inc. (TSLA) | $612.6M | 1.0% | Add 220.88% |
| Exelixis, Inc. (EXEL) | $609.9M | 0.9% | Reduce 10.00% |
| Costco Wholesale Corporation (COST) | $597.6M | 0.9% | Add 5,220.96% |
| Carvana Co. (CVNA) | $594.0M | 0.9% | Add 38.92% |
This table underscores Renaissance's anti-concentration philosophy—even the largest position (PLTR at 2.4%) is modest in a $64.5B behemoth, enabling high-turnover 34.1% without outsized risk. Massive adds like NFLX 2,544% and COST 5,221% show conviction scaling when models align, while reductions (e.g., UTHR -12%, VRSN -12%) enforce discipline.
The balanced changes—5 adds, 5 reduces—reveal systematic rebalancing, with net exposure tilting toward tech momentum amid portfolio shrinkage.
Investment Lessons from Renaissance Technologies' Quant Mastery
- Exploit momentum at scale: Explosive ramps in NFLX, TSLA, and COST demonstrate letting data-driven signals compound winners across thousands of positions.
- Diversify ruthlessly: 12.1% top-10 concentration across 3,184 holdings teaches risk diffusion via sheer breadth, not big bets.
- Embrace high turnover: 34% rate with 16-quarter avg hold proves consistent small edges beat long holds in quant regimes.
- Prune without mercy: Reductions in UTHR, VRSN, EXEL highlight algorithmic exits from fading signals.
- Sector agility rules: Shifts from gold (KGC trim) to AI/chips (PLTR, MU) show adapting to macro rotations.
Looking Ahead: What Comes Next?
Renaissance's trimmed portfolio (down 416 positions) suggests cash redeployment into fresh quant signals, potentially amplifying tech/AI bets if momentum persists into 2026. High turnover implies ongoing churn, targeting undervalued growth amid rate cuts or volatility spikes—watch for semis (MU expansion) and disruptors (CVNA-like plays).
Current positioning sets up for regime shifts: heavy tech exposure thrives in bull markets, while biotech/gold hedges buffer downturns. With $64.5B firepower, expect bold new initiations in emerging trends like AI infrastructure, per their data-hungry models.
FAQ about Renaissance Technologies Portfolio
Q: What are the biggest changes in Renaissance's Q4 2025 13F?
A: Standouts include massive adds like NFLX +2,544.63%, COST +5,220.96%, MU +151%, and TSLA +221%, offset by trims in UTHR -12.15% and VRSN -12.33%.
Q: Why is Renaissance's portfolio so diversified compared to other superinvestors?
A: Their quant strategy spans 3,184 positions with top 10 at just 12.1%, harvesting statistical edges via high turnover 34.1% rather than concentrated conviction bets.
Q: How does Jim Simons' legacy influence current management?
A: Post-Simons, the firm upholds his math-physics roots, with teams running black-box models—succession focuses on algorithmic continuity, not star managers.
Q: Which sectors dominate Renaissance's top holdings?
A: Tech/AI (PLTR, MU), biotech (UTHR, EXEL), and growth consumer (COST, CVNA) lead, with gold (KGC) for diversification.
Q: How can I track Renaissance Technologies' 13F filings and portfolio?
A: Use ValueSense's Renaissance tracker for real-time 13F updates (note 45-day lag), intrinsic value tools, and alerts on changes—ideal for following quant moves without manual SEC digging.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2026)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!